“Beleave is focused on providing a high quality product to supply the medical cannabis market. We have just completed the acquisition of Medi-Green which is three clinics and over 4,000 patients. We’re fully licensed, financially sound and well-funded. We are completing an 80,000 square foot greenhouse and our revenues are growing through a larger customer base.” – Andrew Wnek, CEO of Beleave Inc.
Beleave Inc. is a biotech company and Beleave’s wholly-owned subsidiary Beleave Kannabis Corp.
(formerly First Access Medical Inc.) is a licensed producer pursuant to the ACMPR. Beleave’s
purpose-built facility is located in Hamilton, Ontario.
Our Passion for what we do come from a place of compassion. With determination & commitment, we believe that when used properly, medicinal cannabis has the potential for treatment of symptoms associated with a variety of disorders.
For more information on Beleave Inc. (CSE:BE) please fill out the form below.